|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q3 FY2022
As of Jun 30, 2022
|
Q2 FY2022
As of Mar 31, 2022
|
Q1 FY2022
As of Dec 31, 2021
|
Q4 FY2021
As of Sep 30, 2021
|
Q3 FY2021
As of Jun 30, 2021
|
Q2 FY2021
As of Mar 31, 2021
|
Q1 FY2021
As of Dec 31, 2020
|
Q4 FY2020
As of Sep 30, 2020
|
Q3 FY2020
As of Jun 30, 2020
|
Q2 FY2020
As of Mar 31, 2020
|
Q1 FY2020
As of Dec 31, 2019
|
Q4 FY2019
As of Sep 30, 2019
|
Q3 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Dec 31, 2018
|
Q4 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Mar 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowance for doubtful accounts | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Note receivable | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Investment in equity method investees | ||||||||||||||||||||
| Investments in affiliates | ||||||||||||||||||||
| Investment | ||||||||||||||||||||
| Deposits and other assets | ||||||||||||||||||||
| Intellectual property, net | ||||||||||||||||||||
| Note receivable, long term | ||||||||||||||||||||
| Right of use asset | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Due from related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total due from related party | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Convertible notes, net | ||||||||||||||||||||
| Convertible notes, net related party | ||||||||||||||||||||
| Current maturities of long-term debt | ||||||||||||||||||||
| Short term notes and advances | ||||||||||||||||||||
| Settlement payable | ||||||||||||||||||||
| Acquisition notes payable | ||||||||||||||||||||
| Contingent acquisition liability | ||||||||||||||||||||
| Due to related party | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Lease liability | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Lease liability - long term | ||||||||||||||||||||
| Acquisition payable - long term | ||||||||||||||||||||
| Finance liability | ||||||||||||||||||||
| Long-term debt, mortgages | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity | ||||||||||||||||||||
| Common stock, $0.001 par value; 750,000,000 shares authorized; 2,810,094 and 2,270,140 shares issued, issuable and outstanding as of September 30, 2023 and September 30, 2022, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Stock subscription receivable | ||||||||||||||||||||
| Distribution | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stem Holdings stockholder’s equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total shareholders’ equity (deficit) | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
